Markets.com Logo

AKESF

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    21.1427$
  • Previous Close
    21.1427$
  • 52 Week Change
    16.64$
  • Day Range
    0.00$
  • 52 Week High/Low
    5.68$ - 22.32$
  • Dividend Per Share
    --
  • Market cap
    18 804 M$
  • EPS
    --
  • Beta
    0.44
  • Volume
    --

About

AKESF.US represents the over-the-counter (OTC) traded stock of Akers Biosciences Inc., a company involved in the development, manufacturing, and commercialization of rapid health information technologies. Akers Bio's primary focus historically involved point-of-care testing solutions, particularly for allergies and other health conditions. However, the company has faced financial difficulties and has been subject to significant changes in its business operations and organizational structure over recent years, potentially impacting its current activities and future prospects. As of late 2023, the ticker AKESF is associated with Akers Biosciences Inc., which is operating under a new name, MyMD Pharmaceuticals, Inc. (MYMD).

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

AKESF.US stock price, representing Antengene Corporation, is influenced by several factors. Clinical Trial Results: Positive data from Antengene's clinical trials often drives the stock price upward, while negative results can cause a decline. Regulatory Approvals: Approval of Antengene's drugs by regulatory bodies like the FDA or EMA significantly boosts investor confidence and stock value. Market Sentiment: Overall market conditions and investor risk appetite affect AKESF.US, with bullish markets generally supporting the stock. Competition: The competitive landscape in oncology and hematology, including rival drugs and therapies, can impact Antengene's market share and stock price. Financial Performance: Antengene's revenue, earnings, and cash flow influence investor perceptions of the company's value and future prospects. Partnerships and Collaborations: Strategic alliances with other pharmaceutical companies or research institutions can positively impact the stock. Management Team: Investors' confidence in Antengene's leadership and their ability to execute the company's strategy affects the stock. Economic Factors: Macroeconomic factors like interest rates, inflation, and currency exchange rates can indirectly impact AKESF.US.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--